Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 28;11(10):2663.
doi: 10.3390/biomedicines11102663.

The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue

Affiliations
Review

The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue

Marialuisa Zedde et al. Biomedicines. .

Abstract

Small vessel diseases (SVD) is an umbrella term including several entities affecting small arteries, arterioles, capillaries, and venules in the brain. One of the most relevant and prevalent SVDs is cerebral amyloid angiopathy (CAA), whose pathological hallmark is the deposition of amyloid fragments in the walls of small cortical and leptomeningeal vessels. CAA frequently coexists with Alzheimer's Disease (AD), and both are associated with cerebrovascular events, cognitive impairment, and dementia. CAA and AD share pathophysiological, histopathological and neuroimaging issues. The venular involvement in both diseases has been neglected, although both animal models and human histopathological studies found a deposition of amyloid beta in cortical venules. This review aimed to summarize the available information about venular involvement in CAA, starting from the biological level with the putative pathomechanisms of cerebral damage, passing through the definition of the peculiar angioarchitecture of the human cortex with the functional organization and consequences of cortical arteriolar and venular occlusion, and ending to the hypothesized links between cortical venular involvement and the main neuroimaging markers of the disease.

Keywords: AD; Alzheimer’s disease; CAA; ascending venule; cerebral amyloid angiopathy; cortical angioarchitecture; descending artery; glymphatic system; microbleeds; microinfarction; perivascular spaces; pial network; venule.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Acute cortical microinfarctions (red and blue arrows) on MRI (axial FLAIR sequence in (a), DWI sequence in (b) and ADC map in (c) in a patient with CAA-related inflammation.
Figure 2
Figure 2
Multiple EPVSs in the CSO and the subcortical WM in T2W-MRI in the coronal plane at the hippocampi (a) and occipital poles (b) level. The red arrows point to the EPVSs.
Figure 3
Figure 3
Multiple cortical MBs in a patient with CAA in SWI-MRI reconstructed in axial (a) sagittal (b) and coronal (c) plane. The red arrows point to the potential connection of MBs with cortical venules.

References

    1. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701. doi: 10.1016/S1474-4422(10)70104-6. - DOI - PubMed
    1. Charidimou A., Boulouis G., Gurol M.E., Ayata C., Bacskai B.J., Frosch M.P., Viswanathan A., Greenberg S.M. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017;140:1829–1850. doi: 10.1093/brain/awx047. - DOI - PMC - PubMed
    1. Brenowitz W.D., Nelson P.T., Besser L.M., Heller K.B., Kukull W.A. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer’s disease and other cerebrovascular neuropathologic changes. Neurobiol. Aging. 2015;36:2702–2708. doi: 10.1016/j.neurobiolaging.2015.06.028. - DOI - PMC - PubMed
    1. Iturria-Medina Y.I., Sotero R.C., Toussaint P.J., Mateos-Pérez J.M., Evans A.C., Alzheimer’s Disease Neuroimaging Initiative Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis. Nat. Commun. 2016;7:11934. doi: 10.1038/ncomms11934. - DOI - PMC - PubMed
    1. Sweeney M.D., Sagare A.P., Zlokovic B.V. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 2018;14:133–150. doi: 10.1038/nrneurol.2017.188. - DOI - PMC - PubMed